Company Announcements

2021 Update on asparaginase Erwinia chrysanthemi/ crisantaspase (Erwinia L-asparaginase) Supply Distribution by Jazz

Last updated 16 July 2021

The last batch of global asparaginase Erwinia chrysanthemi/crisantaspase (Erwinia L-asparaginase) distribution by Jazz has been released, and this was the last batch made available by Porton Biopharma Limited (PBL) to Jazz. Jazz’s right to distribute the product ceased after this batch. All supply beyond this batch is the responsibility of PBL and Clinigen.

Any questions related to future batch availability should be directed to PBL’s new partner, Clinigen.

Jazz thanks the healthcare providers, health authorities and patient community for their engagement and partnership over the last several years and the company remains committed to this patient population.